Edition:
India

People: Molecular Medicine SpA (MLMD.MI)

MLMD.MI on Milan Stock Exchange

0.49EUR
18 May 2018
Change (% chg)

€-0.00 (-0.10%)
Prev Close
€0.49
Open
€0.49
Day's High
€0.50
Day's Low
€0.49
Volume
1,782,070
Avg. Vol
4,117,939
52-wk High
€0.60
52-wk Low
€0.40

Rizzardi, Gian Paolo 

Dr. Gian Paolo Rizzardi serves as General Manager at Molecular Medicine S.p.A. He was Director of Research & Development of Molecular Medicine S.p.A. from July 2011. He has more than 15 years’ experience in research on immunotherapeutic strategies, particularly in the areas of HIV/AIDS and infectious diseases: he contributed to the HIV/AIDS field with important studies on HIV immune-pathogenesis and with the design and development of immunomodulatory therapeutic strategies. Working at the Company, he also developed experience in the fields of tumor homing peptides and of vascular targeting agents. He is Author of more than 60 peer-reviewed publications and, together with Mr. Giuseppe Pantaleo, won the Pfizer Prize for research in infectious diseases in 1999. He has served as University Lecturer of Internal Medicine, Immunology, Infectious Disease and Biotechnology in Italy, Switzerland and the United States. He gained a Doctorate of Medicine in Medicine from Universita degli Studi di Milano in 1991.

Basic Compensation

Total Annual Compensation, EUR 259,000
Restricted Stock Award, EUR --
Long-Term Incentive Plans, EUR --
All Other, EUR 3,000
Fiscal Year Total, EUR 262,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --